Mavroudis C, Harrison H, Klein J B, Gray L A, Ganzel B L, Wellhausen S R, Elbl F, Cook L N
Department of Surgery, University of Louisville School of Medicine, Ky 40292.
J Thorac Cardiovasc Surg. 1988 Dec;96(6):912-24.
Infant orthotopic cardiac transplantation has been recently applied to various forms of congenital heart disease with encouraging short-term results. Between June 1986 and September 1987 we evaluated 16 infants for orthotopic cardiac transplantation. Fourteen had hypoplastic left heart syndrome, one had endocardial fibroelastosis with aortic atresia, and one had anomalous pulmonary arterial origin of the left main coronary. Eight families accepted the treatment program and eight families refused (two because of associated anomalies and six on philosophical grounds). Of the eight patients who were candidates for orthotopic cardiac transplantation, one died 6 hours after diagnosis, one was allowed to die after 60 days because of acquired neurologic complications, and another had congenital cytomegalic virus infection. The remaining five patients (four with hypoplastic left heart syndrome, one with anomalous pulmonary arterial origin of the left main coronary) had orthotopic cardiac transplantation. The operation was performed with absorbable polydioxanone suture with deep hypothermia and circulatory arrest in four neonates for hypoplastic left heart syndrome (average time 47 minutes) and bicaval cannulation and continuous bypass in one 11-month-old infant for anomalous origin of the left main coronary. In-house retrieval was used in all. One neonate died of complications as a result of pretransplant donor heart dysfunction and size discrepancy, whereas the remaining three neonates and one infant survived and are home 23 months, 12 months, and 8 months (the patients with hypoplastic left heart syndrome) and 17 months (the patient with anomalous origin of the left main coronary) postoperatively. Triple-drug immunosuppression included cyclosporine, azathioprine, and prednisone. Rejection was diagnosed by clinical evaluation of child activity and monocyte cell cycle analysis from peripheral blood samples without myocardial biopsies. Routine echocardiograms, electrocardiograms, and chest x-ray films were not helpful. Six episodes of rejection were successfully treated in four patients. Twelve-month postoperative catherization in one patient (hypoplastic left heart syndrome) showed appropriate graft growth, no aortic or pulmonary anastomotic strictures, normal right and left ventricular function, and no coronary artery disease. We conclude that infant orthotopic cardiac transplantation is an acceptable procedure for severe forms of untreatable congenital heart disease. The excellent short-term results warrant continued application of orthotopic cardiac transplantation.
婴儿原位心脏移植最近已应用于各种形式的先天性心脏病,短期效果令人鼓舞。1986年6月至1987年9月期间,我们对16名婴儿进行了原位心脏移植评估。其中14例患有左心发育不全综合征,1例患有心内膜弹力纤维增生症合并主动脉闭锁,1例患有左主冠状动脉起源于肺动脉异常。8个家庭接受了治疗方案,8个家庭拒绝(2个因合并其他异常,6个基于哲学原因)。在8名原位心脏移植候选患者中,1例在诊断后6小时死亡,1例因获得性神经并发症在60天后放弃治疗,另1例患有先天性巨细胞病毒感染。其余5例患者(4例左心发育不全综合征,1例左主冠状动脉起源于肺动脉异常)接受了原位心脏移植。4例左心发育不全综合征的新生儿在深低温和循环停止下,使用可吸收聚二氧六环酮缝线进行手术(平均时间47分钟),1例11个月大的婴儿因左主冠状动脉起源异常,采用双腔静脉插管和持续体外循环进行手术。所有病例均采用院内供心获取。1例新生儿因移植前供心功能障碍和大小差异导致的并发症死亡,其余3例新生儿和1例婴儿存活,分别在术后23个月、12个月和8个月(左心发育不全综合征患者)以及17个月(左主冠状动脉起源异常患者)出院回家。三联免疫抑制药物包括环孢素、硫唑嘌呤和泼尼松。通过对儿童活动的临床评估以及外周血样本的单核细胞细胞周期分析来诊断排斥反应,无需进行心肌活检。常规超声心动图、心电图和胸部X线片对此并无帮助。4例患者的6次排斥反应均得到成功治疗。1例患者(左心发育不全综合征)术后12个月的心脏导管检查显示移植心脏生长正常,无主动脉或肺动脉吻合口狭窄,左右心室功能正常,无冠状动脉疾病。我们得出结论,婴儿原位心脏移植对于严重的不可治疗的先天性心脏病是一种可接受的手术方法。出色的短期效果保证了原位心脏移植的持续应用。